Drawing for DOPASTATIN

USPTO serial 78187797

DOPASTATIN

Reviewed by CopyMark Law Group

Reg. 2877062Status 710
Filing date
Status date
Registration date
Aug 24, 2004
Examiner
CARROLL, DORITT
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DOPASTATIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles A. Muserlian

CHARLES A MUSERLIAN HEDMAN & COSTIGAN20TH FL1185 AVE OF THE AMERICASNEW YORK, NY 10036

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in the manufacture of pharmaceutical preparationsSECTION 8 - CANCELLED—
005Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of gastrointestinal diseases; laxatives and purgative agents; pharmaceutical preparations for use in the treatment of cardiovascular diseases; pharmaceutical preparations for use in the treatment pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical preparations for use in the treatment of urological diseases;pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations comprising peptides for hormonal treatment and tumor treatment; pharmaceutical preparations for use in the treatment of endocrine disorders; pharmaceutical preparations for use in the treatment of acromegalia and carcinoid tumors; pharmaceutical preparations for use in the treatment of blood diseases; pharmaceutical preparations for use in the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for use in the treatment of muscle disorders; pharmaceutical preparations for use in the treatment of age-related disorders; pharmaceutical preparations for use in the treatment of diabetes, diabetes-related disorders; pharmaceutical preparations for use in the treatment of respiratory disorders; pharmaceutical preparations for use in the treatment of ophthalmological disorders; pharmaceutical preparations against cough; pharmaceutical preparations for use in the treatment of vertigo, nausea, vomiting and migraine; pharmaceutical preparations for use in the treatment of disorders and diseases of the reproductive system; pharmaceutical preparations for use in the treatment of glabellar lines, facial wrinkles, asymetries and defects and conditions of the human skin; and Veterinary preparations, namely, veterinary preparations for use in the treatment of gastrointestinal diseases; veterinary laxatives and purgative agent; veterinary preparations for use in the treatment of cardiovascular diseases; veterinary preparations for use in the treatment of circulatory disorders; veterinary preparations for use in the treatment of neurological diseases; veterinary preparations for use in the treatment of urological diseases; veterinary preparations for use in the treatment of blood diseases; and veterinary preparations for use in the treatment of muscle disordersSECTION 8 - CANCELLED—
042Research and development services for chemical and pharmaceutical productsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 27, 2015CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Apr 1, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 15, 2007PRA7REGISTERED - SEC. 7 REQUEST ABANDONED—
Sep 28, 2006PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Nov 28, 2005RRPRRESPONSE RECEIVED TO POST REG. ACTION—
Nov 28, 2005MAILPAPER RECEIVED—
Jun 30, 2005PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
May 20, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 27, 2005MAILPAPER RECEIVED—
Apr 4, 2005MAILPAPER RECEIVED—
Mar 14, 2005PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Dec 3, 2004AMD7SEC 7 REQUEST FILED—
Dec 3, 2004AMD7SEC 7 REQUEST FILED—
Dec 3, 2004MAILPAPER RECEIVED—
Aug 24, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 8, 2004IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 23, 20041.BDSec. 1(B) CLAIM DELETED—
Jun 23, 2004MAILPAPER RECEIVED—
Jun 8, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 16, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2004NPUBNOTICE OF PUBLICATION—
Jan 13, 200444DDSEC. 44(D) CLAIM DELETED—
Jan 12, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 18, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2003MAILPAPER RECEIVED—
Dec 13, 2003GNSLLETTER OF SUSPENSION E-MAILED—
Nov 20, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 20, 2003MAILPAPER RECEIVED—
Nov 6, 2003MAILPAPER RECEIVED—
Nov 5, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 5, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 5, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance